Delivery Order SPE2DB25D3306-SPE2DB25FUCZT
Award Date 9/24/25
Potential Completion Date 9/25/25
Potential Value $8.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $2,491.20 delivery order to AmerisourceBergen Drug Corp for Orilissa 150 mg tablets (7-count package) under a firm fixed price contract type. The award, issued on September 22, 2025, with an ultimate completion date of September 23, 2025, represents a non-competitive delivery order supporting the federal government's pharmaceutical supply chain. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a delivery order valued at $8,264.80 to AmerisourceBergen Drug Corp for Orilissa 150 mg tablets (7-count packages) on September 15, 2025, with completion scheduled for September 16, 2025. This firm fixed-price delivery order is not set-aside and represents a non-competitive award to the established prime contractor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor...
- The Defense Logistics Agency awarded a delivery order valued at $1,205.70 to AmerisourceBergen Drug Corp for the supply of Orilissa 150 mg tablets (quantity 7) on April 29, 2025, with completion scheduled for April 30, 2025. This competitively awarded, firm fixed price delivery order carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. Orilissa is a prescription medication used in women's healthcare, reflecting the broad...
- The Defense Logistics Agency awarded a $2,321.58 delivery order to AmerisourceBergen Drug Corp for the supply of Orilissa 150 mg tablets (quantity: 7 units) on July 14, 2025, with an ultimate completion date of July 15, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $68,576.46 delivery order to AmerisourceBergen Drug Corp for the supply of Orilissa 150 mg tablets (seven-count units) under a firm fixed price contract. The contract was competitively awarded with no set-aside designation and includes an ultimate completion date of September 8, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Orilissa 150 mg tablets in quantities of 7 units, valued at $8,696.28. This firm fixed-price delivery order, which was not set-aside, was awarded on July 23, 2025, with an ultimate completion date of July 24, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract action under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Orilissa 200 mg tablets (14-count packaging) with a ceiling value of $8,559.49 under a firm fixed-price contract. This non-set-aside award was competitively procured and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,493.91 to AmerisourceBergen Drug Corp for 7 tablets of Orilissa 150 mg on September 8, 2025, with a completion date of September 9, 2025. This firm fixed-price delivery order, which is not a set-aside contract, represents a procurement of the endometriosis medication Orilissa to support federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of Orilissa 200 mg tablets in quantities of 14 units, with a ceiling value of $10,900.19. This is a firm fixed price delivery order with no set-aside designation, completed competitively. The contract was fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, and has an ultimate completion date of May 21, 2025. This delivery order represents a child...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,188.22, is for the supply of Orilissa 150 mg tablets to support federal healthcare programs. The contract is a firm fixed-price delivery order with a performance period ending on January 8, 2024. It is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...